Clinical Trial

Risk Factors of Paraspinal Muscles in Degenerative Lumbar Spondylolisthesis

Study acronym: RFPMDLS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a retrospectively observational study. The goal of this observational study is to analyze the risk factors of paraspinal muscles associated with the occurrence of spondylolisthesis in patients with degenerative lumbar spondylolisthesis(DLS) and to construct a predictive model. The main question it aims to answer is: Which paraspinal muscle changes are risk factors for DLS? We will collect the information of patients who have undergone lumbar MRI in our hospital and have been diagnosed with back pain ( including spondylolisthesis or no spondylolisthesis) during the period from 2022 to 2024.The collected data included gender, age, body mass index (BMI), diabetes, hypertension, occupation and imaging parameters. We will then retrospectively analyze the risk factors associated with lumbar spondylolisthesis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-23; most recent amendment 2025-03-04.
Trial Details
NCT Number NCT06797700
Lead Sponsor The First People's Hospital of Yunnan
Conditions Spine Degeneration
Enrollment 1,000 participants
Start Date 2025-03-06
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-05